Most read articles by the same author(s)
- Francesco Saverio Mennini, Martina Paoletti, Chiara Bini, Andrea Marcellusi, Marco Falcone, Massimo Andreoni, Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP) , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
- Martina Paoletti, Andrea Marcellusi, Joe Yang, Francesco Saverio Mennini, Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections , Global and Regional Health Technology Assessment: Vol. 10 No. 1 (2023): January-December 2023
- Andrea Marcellusi, Angela Ragonese, Andrea Marinozzi, Alberto Bortolami, Sara Mucherino, Carolina Moreno, Amalia Antenori, Matteo Ferrario, Claudia Simonelli, Matteo Zanuzzi, Marco Cicoira, Ruggero Lasala, Francesco Russoniello, Francesco Attanasio, Caterina Donati, Chiara Roni, Fabrizio Gemmi, Francesco Saverio Mennini, Pierluigi Russo, Giovanna Scroccaro, PierLuigi Canonico, Good practices for the development of budget impact models at regional level , Global and Regional Health Technology Assessment: Vol. 10 No. 1 (2023): January-December 2023
- Andrea Marcellusi, Chiara Bini, Ketty Peris, Paolo Antonio Ascierto, Francesco Saverio Mennini, Cost of illness of cutaneous squamous cell carcinoma (CSCC) , Global and Regional Health Technology Assessment: Vol. 7 No. 1 (2020): January-December 2020
- Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Emanuela Arcangeli, Laura Martinez, Francesc Sorio Vilela, Francesco Saverio Mennini, Cost-utility analysis of evolocumab in patients with ASCVD in Italy , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, Martina Paoletti, Carlo Tomino, Budget Impact analysis of a new system of care in Parkinson’s disease patients , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
- Andrea Marcellusi, Paola Raimondo, Carlotta Galeone, Pier Luigi Canonico, Time to market access in Italy: duration of the P&R process for rare disease drugs , Global and Regional Health Technology Assessment: Vol. 10 No. 1 (2023): January-December 2023
- Chiara Bini, Martina Paoletti, Andrea Marcellusi, Carlo Tomino, Francesco Saverio Mennini, Economic evaluation of treosulfan in patients undergoing allogeneic haematopoietic stem cell transplantation , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
- Francesco S Mennini, Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Alessandro Giunta, Antonio Gasbarrini, Guido Valesini, Pier Luigi Canonico, Ettore Novellino, Valentina Orlando, Alessandra Mecozzi, Teresa Gamucci, Livio Pagano, Eugenio Di Brino, Matteo Ruggeri, Americo Cicchetti, The economic impact of biosimilars in Italy: a scenario analysis , Global and Regional Health Technology Assessment: Vol. 6 No. 1 (2019): January-December 2019
- Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Rosario Cultrera, Francesco Saverio Mennini, Cost-utility of dalbavancin in patients with non-severe ABSSSI in Italy , Global and Regional Health Technology Assessment: Vol. 7 No. 1 (2020): January-December 2020